<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210211050324N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-24</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Sexual counseling based on two models of EX-PLISSIT and BETTER</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effect of sexual counseling based on two models of EX-PLISSIT and BETTER on sexual function and sexual satisfaction of women after Assisted Reproductive Treatment(ART) failure</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55743</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: So far, no counseling program has been offered and implemented in Iran for women seeking treatment failure due to ART, Randomization description: Random Allocation using Random allocation software
Sample of randomization sequence by randomization site
2	2	1	1	1	2	1	2	2	1	2	1
2	1	1	2	1	2	2	1	1	1	2	2
Samples are selected as available and then based on the randomly generated sequence (code 1 or 2), the women are placed in the EX-PLISSIT or BETTER group, respectively.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Sexual counseling.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the EX-PLISSIT sex counseling group, 4 sessions of 60-90 minute individual counseling will be performed in 4 consecutive weekly sessions based on the EX-PLISSIT model. The first three stages of the model, namely the stages (Permission giving, Limited Information, Specific Suggestion) will be performed during 4 counseling sessions. Upon arrival to the fourth level (Intensive therapy) in each of the sessions,  refer to the relevant specialist will be held. Intervention 2: Intervention group: In the sexual counseling group based on the BETTER model, 4 sessions of individual counseling of 60 to 90 minutes will be performed in 4 consecutive weekly sessions based on the BETTER  model. The sessions will be in the form of a preliminary plan, assessment of the patient's sexual status with the aim of clarifying the relationship  between the disease and the client's current condition, informing the client by providing correct information and initial sexual education. Completing the counseling process in the form of sexual education and training will focus on the outcome variable of the intervention, namely sexual function and satisfaction. Finally, the consultation sessions will be summarized. Intervention 3: Control group: Routine interventions will be performed in the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals

When:
َAccess  period starts 6 months after the results are published

To whom:
Researchers and students of academic institutions

Conditions:
With citing to the current study and without altering in data

Where to obtain:
Contact the author responsible for response via Email or phone:rahimisa982@mums.ac.ir    Tel:09928548691

How to obtain:
The request for access to data/documents will be reviewed by the researcher team

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Akram Rahimi Shandiz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ibn Sina ST</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>rahimisa982@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>ّFatemeh Zahra Karimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ibn Sina st, School Of Nursing and Midwifery</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>rahimisa982@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Iranian and living in Mashhad
Age of 18-45 years old
Have at least a fifth grade education
Diagnosis of primary infertility based on information in the patient's file
Failure of one of the methods of assisted reproduction such as (IUI, ICSI, IVF, GIFT, ZIFT)
At least 6 months passed since infertility treatment failure
Not being treated for infertility now and for the past 6 months
Having sex at least once a week
Absence of disease that affect sexual function in woman and her spouse
Not taking drugs that affect sexual function by the woman and her spouse
Non-addiction to tobacco and alcohol by woman and her spouse
Absence of sexual dysfunction in the spouse
Absence of severe depression, stress or anxiety according to the DASS-21 scale
Not receiving sexual counseling for the past 6 months
Having a device to use cyberspace</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Absence from a counseling session
Reluctance to continue cooperation
Occurrence of stressful events during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the EX-PLISSIT sex counseling group, 4 sessions of 60-90 minute individual counseling will be performed in 4 consecutive weekly sessions based on the EX-PLISSIT model. The first three stages of the model, namely the stages (Permission giving, Limited Information, Specific Suggestion) will be performed during 4 counseling sessions. Upon arrival to the fourth level (Intensive therapy) in each of the sessions,  refer to the relevant specialist will be held.</i_keyword>
      <i_keyword>Intervention group: In the sexual counseling group based on the BETTER model, 4 sessions of individual counseling of 60 to 90 minutes will be performed in 4 consecutive weekly sessions based on the BETTER  model. The sessions will be in the form of a preliminary plan, assessment of the patient's sexual status with the aim of clarifying the relationship  between the disease and the client's current condition, informing the client by providing correct information and initial sexual education. Completing the counseling process in the form of sexual education and training will focus on the outcome variable of the intervention, namely sexual function and satisfaction. Finally, the consultation sessions will be summarized.</i_keyword>
      <i_keyword>Control group: Routine interventions will be performed in the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Female sexual function. Timepoint: Before sexual counselling and 4 weeks after last counseling session. Method of measurement: Score obtained by the subject of the Female Sexual Function Index (FSFI) questionnaire. This questionnaire with 19 questions examines women's sexual function in 6 domains of desire(6 questions), arousal(4 questions), lubrication(4questions), orgasm(3 questions), pain discomfort(3 questions) and sexual satisfaction(3questions). The full-scale score is obtained by adding the six domain scores. Higher scores indicates greater sexual functioning. The overall score is a minimum of 2 and a maximum of 6.</prim_outcome>
      <prim_outcome>Women's sexual satisfaction. Timepoint: Before sexual counselling and 4 weeks after last counseling session. Method of measurement: Score obtained by the subject of the Sexual Satisfaction Scale of Women(sssw). This questionnaire contains 30 questions. Scoring is strongly agree(score 1), slightly agree(score 2), neither agree nor disagree ( score 3), slightly disagree(score 4) and strongly disagree(score 5). Questions 1, 4, 5, 6, 9, 10, 11, 12 are scored in reverse. Scores of each domain are obtained from the sum of the scores of that domain. Higher scores indicates greater sexual satisfaction.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-23</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical sciences</contact_name>
        <contact_address>School of Nursing and Midwifery, Ibn Sina St, Mashhad Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
